Ocugen
OCGN

Ocugen (OCGN) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
Canaccord GenuityMaintainedBuy$11.00 from $12.00May 27, 2026
HC Wainwright & Co.MaintainedBuy$10.00 from $7.00Mar 25, 2026
Chardan CapitalMaintainedBuy$7.00Mar 25, 2026
Canaccord GenuityInitiated CoverageBuy$12.00Mar 17, 2026
OppenheimerInitiated CoverageOutperform$10.00Mar 11, 2026
Chardan CapitalMaintainedBuy$7.00Mar 5, 2026
Chardan CapitalMaintainedBuy$7.00Jan 20, 2026
Chardan CapitalMaintainedBuy$7.00Sep 19, 2025
Chardan CapitalMaintainedBuy$7.00Aug 4, 2025
HC Wainwright & Co.MaintainedBuy$7.00Jun 24, 2025
Chardan CapitalMaintainedBuy$7.00Jun 24, 2025
Chardan CapitalMaintainedBuy$7.00May 12, 2025
HC Wainwright & Co.MaintainedBuy$7.00 from $8.00May 12, 2025
HC Wainwright & Co.MaintainedBuy$8.00Mar 6, 2025
Chardan CapitalMaintainedBuy$7.00 from $6.00Mar 6, 2025
HC Wainwright & Co.MaintainedBuy$8.00 from $7.00Feb 13, 2025
Chardan CapitalMaintainedBuy$6.00Feb 13, 2025
Chardan CapitalMaintainedBuy$6.00Jan 23, 2025
HC Wainwright & Co.MaintainedBuy$7.00Jan 13, 2025
Chardan CapitalMaintainedBuy$6.00Nov 18, 2024

Frequently asked questions

  • What is the latest analyst rating on OCGN?

    On May 27, 2026, Canaccord Genuity maintained Ocugen at Buy with a price target of $11.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.